Bulletin 2009/07 - European Patent Office
13.12.2012 • Views
Share Embed Flag

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) I.1(1)<br />

(71) Lek Pharmaceuticals D.D., Verovskova 57,<br />

1526 Ljubljana, SI<br />

(72) AVANZO, Matej, 1000 Ljubljana, SI<br />

ROZMAN PETERKA, Tanja, 1000 Ljubljana,<br />

SI<br />

LEGEN, Igor, 1290 Grosuplje, SI<br />

(74) Prüfer & Partner GbR <strong>European</strong> <strong>Patent</strong><br />

Attorneys, Sohnckestrasse 12, 81479<br />

München, DE<br />

A61K 31/4178 → (51) A61K 31/40<br />

A61K 31/4178 → (51) C<strong>07</strong>D 233/90<br />

A61K 31/4184 → (51) A61K 31/40<br />

A61K 31/4184 → (51) C<strong>07</strong>D 235/08<br />

A61K 31/4245 → (51) C<strong>07</strong>D 271/113<br />

A61K 31/4245 → (51) C<strong>07</strong>D 413/04<br />

A61K 31/427 → (51) C<strong>07</strong>D 213/64<br />

A61K 31/427 → (51) C<strong>07</strong>D 417/12<br />

(51) A61K 31/435 (11) 2 021 003 A2*<br />

A61K 31/55 A61P 37/00<br />

A61P 37/06 A61P 17/06<br />

A61P 3/10 A61P 9/10<br />

(25) En (26) En<br />

(21) <strong>07</strong>795237.2 (22) 24.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/012298 24.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/139833 20<strong>07</strong>/49 06.12.20<strong>07</strong><br />

(88) 31.01.2008<br />

(30) 26.05.2006 US 808770 P<br />

(54) • IMIDAZOAZEPHINONVERBINDUNGEN<br />

• IMIDAZOAZEPHINONE COMPOUNDS<br />

• COMPOSÉS D'IMIDAZO-AZÉPHINONE<br />

(71) Eisai R&D Management Co., Ltd., 6-10,<br />

Koishikawa 4-chome Bunkyo-ku, Tokyo 112-<br />

8088, JP<br />

(72) SPYVEE, Mark, Hampstead, New Hampshire<br />

03841, US<br />

SELETSKY, Boris, Andover, Massachusetts<br />

01810, US<br />

SCHILLER, Shawn, Haverhill, Massachusetts<br />

01832, US<br />

FANG, Francis, Andover, Massachusetts<br />

01810, US<br />

(74) Horner, Martin Grenville, et al, Marks & Clerk<br />

19 Royal Exchange Square, Glasgow G1<br />

3AE, GB<br />

A61K 31/435 → (51) C<strong>07</strong>D 209/20<br />

(51) A61K 31/438 (11) 2 021 004 A2*<br />

(25) En (26) En<br />

(21) <strong>07</strong>756232.0 (22) 08.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/011135 08.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/133561 20<strong>07</strong>/47 22.11.20<strong>07</strong><br />

(88) 02.10.2008<br />

(30) 08.05.2006 US 746680 P<br />

<strong>07</strong>.05.20<strong>07</strong> US 745448<br />

(54) • SUBSTITUIERTE AZASPIRO-DERIVATE<br />

• SUBSTITUTED AZASPIRO DERIVATIVES<br />

• DÉRIVÉS AZASPIRO SUBSTITUÉS<br />

(71) NEUROGEN CORPORATION, 35 Northeast<br />

Industrial Road, Branford, CT 06405, US<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(72) XU, Yuelian, East Haven, CT 06513, US<br />

CALDWELL, Timothy, M., Guilford, CT<br />

06437, US<br />

XIE, Linghong, Guilford, CT 06437, US<br />

CHENARD, Bertrand, L., Waterford, CT<br />

06385, US<br />

(74) Probert, Gareth David, Potter Clarkson LLP<br />

Park View House 58 The Ropewalk, Nottingham<br />

NG1 5DD, GB<br />

A61K 31/438 → (51) C<strong>07</strong>D 471/20<br />

(51) A61K 31/44 (11) 2 021 005 A1*<br />

(25) En (26) En<br />

(21) <strong>07</strong>718834.0 (22) 03.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) AU 20<strong>07</strong>/000587 03.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/128056 20<strong>07</strong>/46 15.11.20<strong>07</strong><br />

(30) 03.05.2006 US 797326 P<br />

(54) • VERFAHREN UND ZUSAMMENSETZUNG<br />

ZUR BEHANDLUNG VON ENTZÜNDLICHEN<br />

SCHMERZEN<br />

• METHODS AND COMPOSITION FOR<br />

TREATMENT OF INFLAMMATORY PAIN<br />

• MÉTHODES ET COMPOSITION POUR<br />

TRAITEMENT D'UNE DOULEUR INFLAM-<br />

MATOIRE<br />

(71) CNSBIO PTY LTD, 1 Collins Street, Melbourne,<br />

VIC 3000, AU<br />

(72) GOODCHILD, Colin Stanley, Malvern, Victoria<br />

3144, AU<br />

(74) Matthews, Derek Peter, Frank B. Dehn & Co.<br />

St Bride's House 10 Salisbury Square,<br />

London EC4Y 8JD, GB<br />

A61K 31/44 → (51) A61K 31/40<br />

A61K 31/44 → (51) C<strong>07</strong>D 213/63<br />

A61K 31/4412 → (51) A61K 31/4015<br />

A61K 31/4412 → (51) C<strong>07</strong>D 213/64<br />

A61K 31/4425 → (51) C<strong>07</strong>D 401/06<br />

A61K 31/4439 → (51) C<strong>07</strong>D 413/04<br />

A61K 31/4458 → (51) A61K 9/24<br />

A61K 31/454 → (51) C<strong>07</strong>D 401/12<br />

A61K 31/4704 → (51) C<strong>07</strong>D 309/38<br />

A61K 31/4706 → (51) C<strong>07</strong>D 235/08<br />

(51) A61K 31/496 (11) 2 021 006 A2*<br />

A61P 15/12 A61P 15/00<br />

(25) En (26) En<br />

(21) <strong>07</strong>728833.0 (22) <strong>07</strong>.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 20<strong>07</strong>/054380 <strong>07</strong>.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/128802 20<strong>07</strong>/46 15.11.20<strong>07</strong><br />

(88) 12.06.2008<br />

(30) 09.05.2006 US 746817 P<br />

14.<strong>07</strong>.2006 US 830987 P<br />

(54) • VERWENDUNG VON FLIBANSERIN ZUR<br />

BEHANDLUNG VON POSTMENOPAUSA-<br />

LEN STÖRUNGEN DES SEXUELLEN VER-<br />

LANGENS<br />

• USE OF FLIBANSERIN FOR THE TREAT-<br />

MENT OF POST-MENOPAUSAL SEXUAL<br />

DESIRE DISORDERS<br />

39<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>07</strong>/<strong>2009</strong>) 11.02.<strong>2009</strong><br />

• UTILISATION DE FLIBANSÉRINE POUR LE<br />

TRAITEMENT DES TROUBLES DE LA<br />

LIBIDO POST-MÉNOPAUSIQUES<br />

(71) Boehringer Ingelheim International GmbH,<br />

Binger Strasse 173, 55216 Ingelheim am<br />

Rhein, DE<br />

(84) AT BE BG CH CY CZ DK EE ES FI FR GB GR<br />

HU IE IS IT LI LT LU LV MC MT NL PL PT RO<br />

SE SI SK TR<br />

(71) Boehringer Ingelheim Pharma GmbH & Co.<br />

KG, Binger Strasse 173, 55216 Ingelheim am<br />

Rhein, DE<br />

(84) DE<br />

(72) POLLENTIER, Stephane, 1871 AW Schoorl,<br />

NL<br />

PYKE, Robert, P.O.Box 368 Ridgefield, CT<br />

06877, US<br />

(74) Hammann, Heinz, Boehringer Ingelheim<br />

GmbH CD-<strong>Patent</strong>s Binger Strasse 173,<br />

55216 Ingelheim am Rhein, DE<br />

A61K 31/4985 → (51) C<strong>07</strong>D 471/14<br />

A61K 31/505 → (51) A61K 31/40<br />

A61K 31/505 → (51) C<strong>07</strong>C 225/20<br />

A61K 31/506 → (51) A61K 39/395<br />

A61K 31/506 → (51) C<strong>07</strong>D 413/04<br />

A61K 31/513 → (51) C<strong>07</strong>D 401/12<br />

A61K 31/54 → (51) C<strong>07</strong>D 401/12<br />

A61K 31/55 → (51) A61K 31/40<br />

A61K 31/55 → (51) A61K 31/435<br />

A61K 31/55 → (51) C<strong>07</strong>D 471/20<br />

A61K 31/555 → (51) A61K 31/01<br />

A61K 31/5575 → (51) C<strong>07</strong>C 405/00<br />

A61K 31/56 → (51) A23L 1/30<br />

A61K 31/59 → (51) C<strong>07</strong>C 401/00<br />

A61K 31/593 → (51) A61K 9/00<br />

(51) A61K 31/685 (11) 2 021 0<strong>07</strong> A2*<br />

A61P 43/00 A61K 8/55<br />

(25) En (26) En<br />

(21) <strong>07</strong>736848.8 (22) 14.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) IT 20<strong>07</strong>/000345 14.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/135703 20<strong>07</strong>/48 29.11.20<strong>07</strong><br />

(88) 10.04.2008<br />

(30) 18.05.2006 IT MI20060981<br />

(54) • PFLASTER ZUR BEHANDLUNG VON CEL-<br />

LULITIS UND LOKALISIERTER ADIPOSI-<br />

TAS<br />

• PATCH FOR THE TREATMENT OF THE<br />

CELLULITE AND LOCALIZED ADIPOSITY<br />

• TIMBRE TRANSDERMIQUE POUR LE<br />

TRAITEMENT DE LA CELLULITE ET DE<br />

L'ADIPOSITÉ LOCALISÉE<br />

(71) Vitrupharma S.r.l., Corso Lodi 34, 20135<br />

Milano, IT<br />

(72) DONNALOJA, Mario, I-20135 Milano, IT<br />

(74) Sarpi, Maurizio, Studio FERRARIO Via Collina,<br />

36, 00187 Roma, IT

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!